X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB SHASUN PHARMA UNICHEM LAB/
SHASUN PHARMA
 
P/E (TTM) x 32.8 123.9 26.5% View Chart
P/BV x 3.5 8.5 40.5% View Chart
Dividend Yield % 0.5 0.2 235.8%  

Financials

 UNICHEM LAB   SHASUN PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
SHASUN PHARMA
Mar-14
UNICHEM LAB/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs33494 354.6%   
Low Rs17446 381.6%   
Sales per share (Unadj.) Rs146.9214.2 68.6%  
Earnings per share (Unadj.) Rs11.95.3 222.9%  
Cash flow per share (Unadj.) Rs16.215.8 102.3%  
Dividends per share (Unadj.) Rs2.001.00 200.0%  
Dividend yield (eoy) %0.81.4 55.0%  
Book value per share (Unadj.) Rs105.153.3 197.1%  
Shares outstanding (eoy) m90.8456.62 160.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.70.3 529.8%   
Avg P/E ratio x21.413.1 163.0%  
P/CF ratio (eoy) x15.74.4 355.1%  
Price / Book Value ratio x2.41.3 184.4%  
Dividend payout %16.818.7 89.7%   
Avg Mkt Cap Rs m23,0733,958 583.0%   
No. of employees `0005.7NA-   
Total wages/salary Rs m2,5582,164 118.2%   
Avg. sales/employee Rs Th2,352.5NM-  
Avg. wages/employee Rs Th450.9NM-  
Avg. net profit/employee Rs Th190.4NM-  
INCOME DATA
Net Sales Rs m13,34612,127 110.0%  
Other income Rs m192229 83.7%   
Total revenues Rs m13,53812,356 109.6%   
Gross profit Rs m1,6391,009 162.4%  
Depreciation Rs m390594 65.7%   
Interest Rs m29415 6.9%   
Profit before tax Rs m1,412230 614.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40 1,233.3%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293-73 -402.5%   
Profit after tax Rs m1,080302 357.6%  
Gross profit margin %12.38.3 147.6%  
Effective tax rate %20.7-31.7 -65.5%   
Net profit margin %8.12.5 324.9%  
BALANCE SHEET DATA
Current assets Rs m5,9796,884 86.9%   
Current liabilities Rs m2,4328,456 28.8%   
Net working cap to sales %26.6-13.0 -205.1%  
Current ratio x2.50.8 302.0%  
Inventory Days Days6362 102.3%  
Debtors Days Days60108 56.1%  
Net fixed assets Rs m6,4034,970 128.8%   
Share capital Rs m182113 160.4%   
"Free" reserves Rs m9,2932,875 323.2%   
Net worth Rs m9,5483,020 316.2%   
Long term debt Rs m2301,817 12.7%   
Total assets Rs m12,84313,347 96.2%  
Interest coverage x50.01.6 3,220.8%   
Debt to equity ratio x00.6 4.0%  
Sales to assets ratio x1.00.9 114.4%   
Return on assets %8.65.4 160.7%  
Return on equity %11.310.0 113.1%  
Return on capital %14.313.3 107.6%  
Exports to sales %29.246.4 63.0%   
Imports to sales %6.314.2 44.5%   
Exports (fob) Rs m3,9005,622 69.4%   
Imports (cif) Rs m8471,728 49.0%   
Fx inflow Rs m4,3565,843 74.6%   
Fx outflow Rs m1,1622,173 53.5%   
Net fx Rs m3,1943,669 87.0%   
CASH FLOW
From Operations Rs m1,119398 281.5%  
From Investments Rs m-853-1,635 52.2%  
From Financial Activity Rs m-3341,309 -25.5%  
Net Cashflow Rs m-6871 -95.9%  

Share Holding

Indian Promoters % 50.1 39.2 127.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 3.6 419.4%  
FIIs % 3.0 17.6 17.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 39.6 80.1%  
Shareholders   20,176 20,750 97.2%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ALKEM LABORATORIES  PLETHICO PHARMA  WOCKHARDT LTD.  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 19, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS